Login
$LFVN
$4.77 -$0.20 (4.02%) Live

$LFVN SEC Filings

Filed On Filing
16 Nov 2026 Form 4: Beindorff Michael A, Director

Sold 10,000 shares ($48.9K)

12 Nov 2026 8-K: Submission of Matters to a Vote of Security Holders
12 Nov 2026 144
09 Nov 2026 Form 4: Beindorff Michael A, Director

Received 17,888 shares as a grant or award ($105K)

09 Nov 2026 Form 4: Anbalagan Rajendran, Director

Received 17,888 shares as a grant or award ($105K)

09 Nov 2026 Form 4: Lewis Darwin, Director

Received 17,888 shares as a grant or award ($105K)

09 Nov 2026 Form 4: Greer Raymond B, Director

Received 17,888 shares as a grant or award ($105K)

09 Nov 2026 Form 4: Dayton Judd, Director

Received 17,888 shares as a grant or award ($105K)

09 Nov 2026 8-K: Results of Operations and Financial Condition

Salt Lake City, UT, November 9, 2026, LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for i...

09 Nov 2026 10-Q
22 Oct 2026 SCHEDULE 13G/A
09 Oct 2026 Form 4: Cunningham Kristen, Chief Sales Officer

Received 32,850 shares as a grant or award · Granted 49,275 Performance Restricted Stock Units

09 Oct 2026 Form 4: Aure Carl, Chief Financial Officer

Received 35,749 shares as a grant or award · Granted 53,623 Performance Restricted Stock Units

09 Oct 2026 Form 4: Moorehead Terrence, Director

Received 193,237 shares as a grant or award · Granted 289,855 Performance Restricted Stock Units

05 Oct 2026 Form 4: Aure Carl, Chief Financial Officer

Gave up 460 shares to cover exercise price or tax ($2.87K)

05 Oct 2026 Form 4: Cunningham Kristen, Chief Sales Officer

Gave up 637 shares to cover exercise price or tax ($3.97K)

05 Oct 2026 8-K: Amendments to Articles/Bylaws; Change in Fiscal Year

On September 29, 2026, in order to align the fiscal year of LifeVantage Corporation (the “Company”) with the calendar year and better coordinate the Company’s financial reporting and operational management processes, the Board of Directo...

18 Sep 2026 ARS
18 Sep 2026 DEFA14A
18 Sep 2026 Proxy statement: annual meeting on November 5, 2026

say-on-pay vote

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support